rs121918656
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PVS1PS1_ModeratePM2PP5
The ENST00000373588.9(NR5A1):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
NR5A1
ENST00000373588.9 start_lost
ENST00000373588.9 start_lost
Scores
7
7
2
Clinical Significance
Conservation
PhyloP100: 5.89
Genes affected
NR5A1 (HGNC:7983): (nuclear receptor subfamily 5 group A member 1) The protein encoded by this gene is a transcriptional activator involved in sex determination. The encoded protein binds DNA as a monomer. Defects in this gene are a cause of XY sex reversal with or without adrenal failure as well as adrenocortical insufficiency without ovarian defect. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in ENST00000373588.9 (NR5A1) was described as [Pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-124503393-C-T is Pathogenic according to our data. Variant chr9-124503393-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 12806.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr9-124503393-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR5A1 | NM_004959.5 | c.3G>A | p.Met1? | start_lost | 2/7 | ENST00000373588.9 | NP_004950.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR5A1 | ENST00000373588.9 | c.3G>A | p.Met1? | start_lost | 2/7 | 1 | NM_004959.5 | ENSP00000362690 | P1 | |
NR5A1 | ENST00000620110.4 | c.3G>A | p.Met1? | start_lost | 2/6 | 5 | ENSP00000483309 | |||
NR5A1 | ENST00000455734.1 | c.3G>A | p.Met1? | start_lost | 2/4 | 3 | ENSP00000393245 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Premature ovarian failure 7 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 19, 2009 | - - |
46,XY sex reversal 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 19, 2009 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationTaster
Benign
A
PROVEAN
Benign
.;N;N
REVEL
Pathogenic
Sift
Uncertain
.;D;D
Sift4G
Uncertain
D;D;.
Polyphen
0.94
.;P;.
Vest4
MutPred
Gain of catalytic residue at M1 (P = 0.0542);Gain of catalytic residue at M1 (P = 0.0542);Gain of catalytic residue at M1 (P = 0.0542);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at